Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids

Oncotarget

Volumn 6, Issue 28, 2015, Pages 24699-24708

  Zhang, Kun ^a,b   Liu, Yu ^c   Liu, Xiaoqiang ^a   Chen, Jie ^a,b   Cai, Qingqing ^d   Wang, Jingfeng ^a,b   Huang, Hui ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Key Laboratory of Cardiac Electrophysiology and Arrhythmia in Guangdong Province   (China)

^c PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Apocynin; Cardiac remodeling; Chronic renal failure; Epoxyeicosatrienoic acids; Pathology Section

Indexed keywords

14,15 DIHYDROXYEICOSATRIENOIC ACID; APOCYNIN; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; MESSENGER RNA; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; 14,15-DIHYDROXYEICOSATRIENOIC ACID; ACETOPHENONE DERIVATIVE; ANGIOTENSIN II; CARDIOTONIC AGENT; DIHOMO GAMMA LINOLENIC ACID;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIAC REMODELING; CARDIORENAL SYNDROME; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; GENE EXPRESSION; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE POSTERIOR WALL THICKNESS; HEART LEFT VENTRICLE WEIGHT; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CARDIAC MUSCLE CELL; CARDIO-RENAL SYNDROME; CELL LINE; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; FIBROSIS; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

8,11,14-EICOSATRIENOIC ACID; ACETOPHENONES; AGED; ANGIOTENSIN II; ANIMALS; CARDIO-RENAL SYNDROME; CARDIOTONIC AGENTS; CELL LINE; DISEASE MODELS, ANIMAL; EPOXIDE HYDROLASES; FEMALE; FIBROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; RATS, SPRAGUE-DAWLEY; STROKE VOLUME; UP-REGULATION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84944472841     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5084     Document Type: Article

References (32)

1. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006; 17:2034-47.
2. Yogi A, Callera GE, Tostes R, Touyz RM. Bradykinin regulates calpain and proinflammatory signaling through TRPM7-sensitive pathways in vascular smooth muscle cells. Am J Physiol-Reg I. 2009; 296:R201-R7.
3. Zhang H, Wang T, Zhang K, Liu Y, Huang F, Zhu X, Wang MH, Tang W, Wang J, Huang H. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via downregulation of cardiac fibroblasts-derived fibroblast growth factor-2. Crit Care Med. 2014; 42:e345-54.
4. Xu D, Li N, He Y, Timofeyev V, Lu L, Tsai HJ, Kim IH, Tuteja D, Mateo RK, Singapuri A, Davis BB, Low R, Hammock BD, et al. Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A. 2006; 103:18733-8.
5. Zhang K, Wang J, Zhang H, Chen J, Zuo Z, Huang H. Mechanisms of epoxyeicosatrienoic acids to improve cardiac remodeling in chronic renal failure disease. Eur J Pharmacol. 2013; 701:33-9.
6. Liu J, Zhou J, An W, Lin Y, Yang Y, Zang W. Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species. Can J Physiol Pharmacol. 2010; 88:745-52.
7. Li YQ, Li XB, Guo SJ, Chu SL, Gao PJ, Zhu DL, Niu WQ, Jia N. Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice. Acta Pharmacol Sin. 2013; 34:352-9.
8. Mouzaoui S, Djerdjouri B, Makhezer N, Kroviarski Y, El-Benna J, Dang PM. Tumor Necrosis Factor-alpha-Induced Colitis Increases NADPH Oxidase 1 Expression, Oxidative Stress, and Neutrophil Recruitment in the Colon: Preventive Effect of Apocynin. Mediators Inflamm. 2014; 2014:312484.
9. Tain YL, Hsu CN, Huang LT, Lau YT. Apocynin attenuates oxidative stress and hypertension in young spontaneously hypertensive rats independent of ADMA/NO pathway. Free Radic Res. 2012; 46:68-76.
10. Kim JH, Jang BG, Choi BY, Kim HS, Sohn M, Chung TN, Choi HC, Song HK, Suh SW. Post-treatment of an NADPH oxidase inhibitor prevents seizure-induced neuronal death. Brain Res. 2013; 1499:163-72.
11. Kinugasa S, Tojo A, Sakai T, Tsumura H, Takahashi M, Hirata Y, Fujita T. Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase. Kidney Int. 2011; 80:1328-38.
12. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52:1527-39.
13. Fujii H, Nishijima F, Goto S, Sugano M, Yamato H, Kitazawa R, Kitazawa S, Fukagawa M. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress. Nephrol Dial Transplant. 2009; 24:2089-95.
14. Panichi V, Maggiore U, Taccola D, Migliori M, Rizza GM, Consani C, Bertini A, Sposini S, Perez-Garcia R, Rindi P, Palla R, Tetta C. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol Dial Transplant. 2004; 19:1154-60.
15. Zhang J, Chandrashekar K, Lu Y, Duan Y, Qu P, Wei J, Juncos LA, Liu R. Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice. Am J Physiol Renal Physiol. 2014; 306:F344-50.
16. Park YM, Park MY, Suh YL, Park JB. NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem Biophys Res Commun. 2004; 313:812-7.
17. Moe KT, Khairunnisa K, Yin NO, Chin-Dusting J, Wong P, Wong MC. Tumor necrosis factor-alpha-induced nuclear factor-kappaB activation in human cardiomyocytes is mediated by NADPH oxidase. J Physiol Biochem. 2014; 70:769-79.
18. Imig JD. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev. 2012; 92:101-30.
19. Elmarakby AA. Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease. Am J Physiol Regul Integr Comp Physiol. 2012; 302:R321-30.
20. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002; 82:131-85.
21. Gauthier KM, Olson L, Harder A, Isbell M, Imig JD, Gutterman DD, Falck JR, Campbell WB. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles. Am J Physiol Renal Physiol. 2011; 301:F765-72.
22. Pinto A, Abraham NG, Mullane KM. Arachidonic acidinduced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450-dependent pathway. J Pharmacol Exp Ther. 1987; 240:856-63.
23. Cerasola G, Nardi E, Palermo A, Mule G, Cottone S. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. J Nephrol. 2011; 24:1-10.
24. Zhang D, Xie X, Chen Y, Hammock BD, Kong W, Zhu Y. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Circ Res. 2012; 110:808-17.
25. Ai D, Pang W, Li N, Xu M, Jones PD, Yang J, Zhang Y, Chiamvimonvat N, Shyy JY, Hammock BD, Zhu Y. Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Proc Natl Acad Sci U S A. 2009; 106:564-9.
26. Liu L, Chen C, Gong W, Li Y, Edin ML, Zeldin DC, Wang DW. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. J Pharmacol Exp Ther. 2011; 339:451-63.
27. Spector AA, Norris AW. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol. 2007; 292:C996-1012.
28. Liu Y, Liu X, Chen J, Zhang K, Huang F, Wang JF, Tang W, Huang H. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition. J Am Heart Assoc. 2015; 4:e001598 doi:10.1161/ JAHA.114.001598 doi: 10.1161/JAHA.114.001598
29. Goulitquer S, Dreano Y, Berthou F, Corcos L, Lucas D. Determination of epoxyeicosatrienoic acids in human red blood cells and plasma by GC/MS in the NICI mode. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 876:83-8.
30. Zhang Y, Chan MM, Andrews MC, Mori TA, Croft KD, McKenzie KU, Schyvens CG, Whitworth JA. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens. 2005; 18:910-6.
31. Morgan LA, Olzinski AR, Upson JJ, Zhao S, Wang T, Eisennagel SH, Hoang B, Tunstead JR, Marino JP Jr, Willette RN, Jucker BM, Behm DJ. Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction after aortic constriction in rats and mice. J Cardiovasc Pharmacol. 2013; 61:291-301.
32. Zhang K, Cheng G, Cai X, Chen J, Jiang Y, Wang T, Wang J, Huang H. Malnutrition, a new inducer for arterial calcification in hemodialysis patients? J Transl Med. 2013; 11:66.